Repository logo
Communities & Collections
All of DSpace
  • English
  • العربية
  • বাংলা
  • Català
  • Čeština
  • Deutsch
  • Ελληνικά
  • Español
  • Suomi
  • Français
  • Gàidhlig
  • हिंदी
  • Magyar
  • Italiano
  • Қазақ
  • Latviešu
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Српски
  • Svenska
  • Türkçe
  • Yкраї́нська
  • Tiếng Việt
Log In
New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Bakare, O. E."

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Results Per Page
  • Sort Options
  • Thumbnail Image
    Item
    Community Pharmacists’ Perception about Mental Healthcare and Barriers to providing Pharmaceutical Care Services to Patients with Mental Disorder in Ibadan, Nigeria
    (Biomedical Journal Consult, 2023) Akande-Sholabi, W.; Bakare, O. E.
    Community pharmacists play a significant role by providing pharmaceutical care for patients with mental disorders. Mental disorder is a health priority in national health strategies around the world, including in Nigeria. However, personal perception and practice-related barriers may prevent full involvement. This study therefore aims to assess community pharmacists’ perception and level of comfort towards mental healthcare, as well as the barriers in providing pharmaceutical care to patients with mental disorder in Ibadan. A cross-sectional study among 120 community pharmacists in Ibadan, using a self-administered questionnaire. Descriptive statistics including frequency and percentage were used to summarize the data. The majority (99;82.5%) agreed they will deal with mentally ill patients, while 81 (67.5%) feel confident and comfortable to provide pharmaceutical care to patients with mental illness. Major barriers to pharmaceutical care cited includes inability to monitor outcomes as patients may never return to the pharmacy again (88; 73.3%) and having only limited patient information (85;70.8%). This corresponds with the revelation that (88; 73.3%) believe that follow up for adverse drug related problem is not easy. About 23% community pharmacies do not stock psychotropic medication at all, mainly due to few requests and tough regulations of record keeping required by law. Despite willingness to provide services to patients with mental illness, reduced stockings of psychotropics and practice-related barriers prevent full participation of community pharmacists.
  • Thumbnail Image
    Item
    Pharmacy students’ knowledge of psychotropic medicines and their attitude towards providing pharmaceutical care to patients with anxiety in Nigeria
    (Nigeria Association of Pharmacists in Academia (NAPA), 2022) Akande-Sholabi, W.|| || ||; Bakare, O. E.; Adebisi, A. Y.; Odeku, O.
    Background: Healthcare professionals, such as pharmacists, play critical roles in the management of mental disorders by assessing the potential for adverse reactions, providing medication counseling, and medication review optimize treatment regimens. Objectives: This study aims to assess the knowledge of pharmacy students in a Nigerian university regarding psychotropic medicines and their attitude towards providing pharmaceutical care to patients with anxiety. Method: A cross-sectional web-based survey was conducted in May 2021 among fourth- and fifth-year pharmacy students in a Nigerian university. The data were summarized using descriptive statistics, such as frequencies and percentages. Chi square was utilized to examine the association between the demographic characteristics and the respondents' overall knowledge and attitude. Results: The response rate was 85%, as 126 responses were received. About half of the respondents 69 (54.8%) reported that they have received training on psychotropic medicines and 9 (9.1%) have been previously diagnosed with anxiety disorders. Only 53 (42.1%) and 71 (56.3%) of our respondents knew that escitalopram and alprazolam are categorized as anxiolytics respectively. Most respondents would like to talk to patients with anxiety about their medications 110 (87.3%), attend training on pharmaceutical care for patients with anxiety 103 (81.7%), and obtain a medication history for people with anxiety 113 (89.7%). Ninety-four (74.6%) pharmacy students would like to suggest prescription medication for a patient with anxiety and only 88 (69.8%) would like to correct any errors in prescription in any anxiety cases. Our findings also revealed that there is a significant association between the students’ attitude and year of study (p=0.038) and previous training on psychotropic medicines (p=0.004). Conclusion: Findings from this study suggested that participants require improved knowledge and training of psychotropic medicines.

DSpace software copyright © 2002-2026 Customised by Abba and King Systems LLC

  • Privacy policy
  • End User Agreement
  • Send Feedback
Repository logo COAR Notify